| Issuer | % book | Value | Since entry | Conviction | Business | Tags |
|---|
| $GLDM · SPDR GOLD MINISHARES TRUST | 4.6% | $266,702,128 | -14% | Med | An exchange-traded fund in the State Street SPDR family (GLDM MiniShares) that holds physical gold bullion in trust to provide lower-cost exposure to the price of gold. | |
| $CG · CARLYLE GROUP INC/THE | 2.5% | $146,720,028 | -5% | Med | The Carlyle Group is a global alternative-asset manager investing across private equity, credit, and real assets, along with insurance-solutions strategies, for institutional clients. | NASDAQ |
| $BX · BLACKSTONE INC | 2.5% | $148,364,698 | +10% | Med | Blackstone is a leading alternative-asset manager investing across private equity, real estate, credit, and hedge-fund strategies on behalf of institutional and individual investors. | S&PBitget → |
| Issuer | % book | Since entry | Business | Tags |
|---|
| $STT · STATE STREET CORP | 43.6% | +57% Q3 '25 | Custody bank and asset management (SPDR ETFs) | S&P |
| $ASML · ASML HOLDING NV NY REG SHS | 15.9% | +81% Q3 '25 | | NASDAQSerenityBitget → |
| $OTF · BLUE OWL TECHNOLOGY FINANCE | 15.6% | -34% Q2 '25 | | |
| $BN · BROOKFIELD CORP | 12.4% | +14% Q4 '24 | Brookfield Corporation is a global owner and manager of real assets and alternative investments, with operations spanning renewable power, infrastructure, real estate, private equity, credit, and insurance. | |
| $GLDM · SPDR GOLD MINISHARES TRUST | 4.6% | -14% Q1 '26 | An exchange-traded fund in the State Street SPDR family (GLDM MiniShares) that holds physical gold bullion in trust to provide lower-cost exposure to the price of gold. | |
| $BX · BLACKSTONE INC | 2.5% | +10% Q1 '26 | Blackstone is a leading alternative-asset manager investing across private equity, real estate, credit, and hedge-fund strategies on behalf of institutional and individual investors. | S&PBitget → |
| $CG · CARLYLE GROUP INC/THE | 2.5% | -5% Q1 '26 | The Carlyle Group is a global alternative-asset manager investing across private equity, credit, and real assets, along with insurance-solutions strategies, for institutional clients. | NASDAQ |
| $FDS · FACTSET RESEARCH SYSTEMS INC | 1.7% | -11% Q4 '25 | | S&P |
| $QTOP · ISHARES NASDAQ TOP 30 STOCKS E | 1.0% | +39% Q4 '24 | | NASDAQ |
| $SRZN · SURROZEN INC | 0.1% | +53% Q4 '24 | Surrozen is a clinical-stage biotechnology company developing antibody therapeutics that modulate the Wnt signaling pathway to promote tissue repair and regeneration. | NASDAQ |